These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 23209847)
21. Serum fatty acids and progression from dengue fever to dengue haemorrhagic fever/dengue shock syndrome. Villamor E; Villar LA; Lozano-Parra A; Herrera VM; Herrán OF Br J Nutr; 2018 Oct; 120(7):787-796. PubMed ID: 30105961 [TBL] [Abstract][Full Text] [Related]
22. Activation of endothelial cells, coagulation and fibrinolysis in children with Dengue virus infection. Sosothikul D; Seksarn P; Pongsewalak S; Thisyakorn U; Lusher J Thromb Haemost; 2007 Apr; 97(4):627-34. PubMed ID: 17393026 [TBL] [Abstract][Full Text] [Related]
23. Serum lactate and lactate dehydrogenase as parameters for the prediction of dengue severity. Sirikutt P; Kalayanarooj S J Med Assoc Thai; 2014 Jun; 97 Suppl 6():S220-31. PubMed ID: 25391197 [TBL] [Abstract][Full Text] [Related]
24. Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesis. Chaturvedi UC; Agarwal R; Elbishbishi EA; Mustafa AS FEMS Immunol Med Microbiol; 2000 Jul; 28(3):183-8. PubMed ID: 10865168 [TBL] [Abstract][Full Text] [Related]
25. Increased level of hepatocyte growth factor in children with dengue virus infection. Voraphani N; Theamboonlers A; Khongphatthanayothin A; Srisai C; Poovorawan Y Ann Trop Paediatr; 2010; 30(3):213-8. PubMed ID: 20828454 [TBL] [Abstract][Full Text] [Related]
26. A three-component biomarker panel for prediction of dengue hemorrhagic fever. Brasier AR; Ju H; Garcia J; Spratt HM; Victor SS; Forshey BM; Halsey ES; Comach G; Sierra G; Blair PJ; Rocha C; Morrison AC; Scott TW; Bazan I; Kochel TJ; Am J Trop Med Hyg; 2012 Feb; 86(2):341-8. PubMed ID: 22302872 [TBL] [Abstract][Full Text] [Related]
28. Clinical findings and pro-inflammatory cytokines in dengue patients in Western India: a facility-based study. Priyadarshini D; Gadia RR; Tripathy A; Gurukumar KR; Bhagat A; Patwardhan S; Mokashi N; Vaidya D; Shah PS; Cecilia D PLoS One; 2010 Jan; 5(1):e8709. PubMed ID: 20090849 [TBL] [Abstract][Full Text] [Related]
29. A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model. Libraty DH; Acosta LP; Tallo V; Segubre-Mercado E; Bautista A; Potts JA; Jarman RG; Yoon IK; Gibbons RV; Brion JD; Capeding RZ PLoS Med; 2009 Oct; 6(10):e1000171. PubMed ID: 19859541 [TBL] [Abstract][Full Text] [Related]
30. Molecular Signatures of Dengue Virus-Specific IL-10/IFN-γ Co-producing CD4 T Cells and Their Association with Dengue Disease. Tian Y; Seumois G; De-Oliveira-Pinto LM; Mateus J; Herrera-de la Mata S; Kim C; Hinz D; Goonawardhana NDS; de Silva AD; Premawansa S; Premawansa G; Wijewickrama A; Balmaseda A; Grifoni A; Vijayanand P; Harris E; Peters B; Sette A; Weiskopf D Cell Rep; 2019 Dec; 29(13):4482-4495.e4. PubMed ID: 31875555 [TBL] [Abstract][Full Text] [Related]
31. Markers of dengue disease severity. Srikiatkhachorn A; Green S Curr Top Microbiol Immunol; 2010; 338():67-82. PubMed ID: 19802579 [TBL] [Abstract][Full Text] [Related]
32. Dengue hemorrhagic fever - A systemic literature review of current perspectives on pathogenesis, prevention and control. Wang WH; Urbina AN; Chang MR; Assavalapsakul W; Lu PL; Chen YH; Wang SF J Microbiol Immunol Infect; 2020 Dec; 53(6):963-978. PubMed ID: 32265181 [TBL] [Abstract][Full Text] [Related]
33. Association Between Increased Vascular Nitric Oxide Bioavailability and Progression to Dengue Hemorrhagic Fever in Adults. Thein TL; Wong J; Leo YS; Ooi EE; Lye D; Yeo TW J Infect Dis; 2015 Sep; 212(5):711-4. PubMed ID: 25732810 [TBL] [Abstract][Full Text] [Related]
34. Immunodominant T-cell responses to dengue virus NS3 are associated with DHF. Duangchinda T; Dejnirattisai W; Vasanawathana S; Limpitikul W; Tangthawornchaikul N; Malasit P; Mongkolsapaya J; Screaton G Proc Natl Acad Sci U S A; 2010 Sep; 107(39):16922-7. PubMed ID: 20837518 [TBL] [Abstract][Full Text] [Related]
35. Dengue Hemorrhagic Fever: A State-of-the-Art Review Focused in Pulmonary Involvement. de Almeida RR; Paim B; de Oliveira SA; Souza AS; Gomes ACP; Escuissato DL; Zanetti G; Marchiori E Lung; 2017 Aug; 195(4):389-395. PubMed ID: 28612239 [TBL] [Abstract][Full Text] [Related]
36. Severity of Plasma Leakage Is Associated With High Levels of Interferon γ-Inducible Protein 10, Hepatocyte Growth Factor, Matrix Metalloproteinase 2 (MMP-2), and MMP-9 During Dengue Virus Infection. Her Z; Kam YW; Gan VC; Lee B; Thein TL; Tan JJ; ; Lee LK; Fink K; Lye DC; Rénia L; Leo YS; Ng LF J Infect Dis; 2017 Jan; 215(1):42-51. PubMed ID: 28077582 [TBL] [Abstract][Full Text] [Related]
37. Neutrophil Activation and Early Features of NET Formation Are Associated With Dengue Virus Infection in Human. Opasawatchai A; Amornsupawat P; Jiravejchakul N; Chan-In W; Spoerk NJ; Manopwisedjaroen K; Singhasivanon P; Yingtaweesak T; Suraamornkul S; Mongkolsapaya J; Sakuntabhai A; Matangkasombut P; Loison F Front Immunol; 2018; 9():3007. PubMed ID: 30687301 [TBL] [Abstract][Full Text] [Related]
38. Characteristics and Risk Factors for Fatality in Patients with Dengue Hemorrhagic Fever, Taiwan, 2014. Wei HY; Shu PY; Hung MN Am J Trop Med Hyg; 2016 Aug; 95(2):322-7. PubMed ID: 27273649 [TBL] [Abstract][Full Text] [Related]